INTRODUCTION
The rectal route has been frequently exploited for the systemic delivery of drugs in situations where it is desirable to avoid hepatic first-pass metabolism 1 or to prolong drug release 2 . For effective retention of medication on the rectal mucosa, the drug delivery system should display a mucoadhesive property. Microspheres have been extensively studied for use as drug delivery systems, where they have been shown to protect sensitive macromolecules from enzymatic and acid degradation, and allow controlled release and tissue targeting of the formulated drug [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] . Microspheres prepared with gelatin as the polymer have been found to be highly mucoadhesive and have been used for the controlled release of many drugs 14 .
Microspheres prepared from admixtures of gelatin and crosslinked chitosan demonstrated some advantage over that prepared from gelatin alone in terms of better controlled release rate of cimetidine 14 . The reported ionic interaction of mucin with many biologically important compounds including polymers 15 suggested that mucoadhesive microspheres could be produced from admixtures of mucin and gelatin. The parenteral route of administration of antibiotics (including cefuroxime sodium) is fraught with myriad of draw-backs especially pain at the injection site which often leads to poor patient compliance or complete non-compliance with its obvious consequences. The rectal route of administration of cefuroxime sodium could, therefore, offer better advantages in terms of enhanced patient compliance and could also be a potential alternative to the parenteral route for the delivery of cefuroxime sodium.
The search for alternative routes of delivery of many drugs including insulin and other peptides is continuing; hence our current efforts to explore the rectal route for the delivery of cefuroxime sodium, an acid labile cephalosporin. The objective of this study was to develop mucoadhesive formulations (microspheres) based on gelatin and its admixtures with porcine mucin with a view to enhancing the rectal delivery of cefuroxime sodium through entrapment into these microspheres. This way, a viable alternative route of delivery of cefuroxime sodium, in addition to the parenteral route, would have been provided.
MATERIALS AND METHODS

Materials
Cefuroxime sodium powder (GlaxoWellcome, England); citric acid, sodium hydroxide (Merck, Germany); acetone, concentrated HCl, glutaraldehyde, disodium hydrogen phosphate, sodium chloride (BDH, England); type A gelatin (75 bloom), monobasic potassium phosphate (Sigma Chemical Co., USA) were used as procured from the manufacturers without further purification. All other reagents were analytical grade and used as such. Distilled water was obtained from an all-glass still. The animal experimental protocols were approved by our institution's Animal Ethics Committee.
Isolation of the porcine mucin
The small intestines of freshly slaughtered pigs (within 1 h post mortem) were obtained from the abattoir of the Animal Science Department in our University and dissected, starting from the jejunum to the ileocaecal sphincter. The intestines, sectioned into short lengths, were flushed through with chilled saline, and the mucosal surface was exposed by longitudinal dissection. By using a microscope slide, the mucus layer was gently scraped off and diluted with four times its volume of distilled water. The gel was homogenized for 2 h at 4 o C and thereafter exhaustively dialysed against distilled water using a 12 KDa molecular weight cut-off (MWCO) dialysis membrane. The dialysate was finally centrifuged at 10,000 rpm for 30 min to yield a supernatant of water-soluble mucus glycoprotein layers and lower layer of insoluble mucus glycoprotein. The supernatants were collected separately, pooled and lyophilized at -40 o C for 48 h to obtain flakes of soluble (S) mucin, which were powdered and used for the study.
Preparation of gelatin-mucin admixtures 1 g quantity of gelatin was dispersed in 50 ml of citrate/phosphate buffer of pH 3.4. An equal amount of S-mucin was similarly weighed out and mixed thoroughly with the dispersion of gelatin in a beaker. The mixture was left to stand for 24 h in order to attain maximum hydration. It was then homogenized by stirring with a glass rod for 5min. The procedure was repeated to obtain S-mucin to gelatin in ratios of 1:1, 1:2, 1:3, and 1:4.
Preparation of the gelatin-mucin microspheres A dispersion of each gelatin-mucin admixture (25 % v/v in arachis oil) was used in the preparation of the microspheres. 1 g of cefuroxime sodium powder was dispersed in 25 ml of the gelatinmucin dispersion and heated until the temperature of the dispersion was brought to 40 o C.
The dispersion was further extruded dropwise, with the aid of a syringe into pure arachis oil maintained at 40 o C on a thermostatically controlled hot plate-magnetic stirrer. The mixture was stirred at a speed of 500 rpm for 30 min. Glutaraldehyde was added to a concentration of about 1 % v/v to cross-link the microspheres in situ and stirred further for 30 min. The resulting mixture was centrifuged at 6000 rpm for 10 min to collect the microspheres. The microspheres collected were washed with acetone to remove excess oil and then dried at the ambient temperature of 28 ± 2 o C.
Determination of entrapment efficiency of the microspheres
A quantity (100 mg) of the microspheres was placed in a beaker containing 100 ml of the citrate/phosphate buffer (pH 7.4) The dispersion was vortexed repeatedly to break up the microspheres and cause them to discharge their drug contents completely. The solution was then filtered and analyzed spectrophotometrically at a wavelength of 280 nm using a UV-Vis spectrophotometer (Spectronic 21D). The drug concentration in each batch of the microspheres was calculated from a Beer's plot previously determined for cefuroxime sodium. An average of five determinations was taken as the mean drug content for each batch of microspheres.
In vitro drug release studies
The USP XXVII paddle method was adopted in this study. The release medium consisted of 500 ml of freshly prepared SIF (pH 7.4) maintained at 37 ± 1 o C. SIF was selected as the release medium since it has a pH very close to that of the rectal fluids. A known quantity (100 mg) of each batch of the microspheres was placed in the appropriate chamber of the release apparatus and agitated at 100 rpm. At predetermined time intervals, 1 ml aliquots of the release medium were withdrawn, appropriately diluted and assayed spectrophotometrically at 280 nm. At every interval, 1 ml of fresh SIF was added to replace the sample that was withdrawn. The concentrations of the withdrawn samples were calculated with reference to the standard Beer's plot. Four replicate release studies were performed in each case and the mean values were taken.
Pharmacokinetic studies
Male Wistar rats aged two months with a mean weight of 200 ± 10.5 g were obtained from the Department of Veterinary Pathology and Microbiology, of our University and used for the study. The rats were allowed to acclimatize to the new environmental conditions of our laboratories for one week before use. Three groups of eight animals each were used for the study.
An amount of the microspheres equivalent to a dose of 100 mg of the drug/kg body weight of the rats was carefully transferred into the empty bodies of capsule no. 3. A positive control was set up by enclosing an equal amount of the pure cefuroxime sodium powder equivalent to that in the microspheres. By means of the capsules the drug was administered rectally to the rats. At regular time intervals of 30 min for the first one hour, and then subsequently at 1 h intervals, 0.5 ml of blood samples were withdrawn from the orbital sinus of the rat 16, 17 .
Analysis of cefuroxime sodium in proteinfree rat plasma
The method of Tietz 18 was adopted to prepare a protein-free filtrate. The blood sample (0.2 ml) was added to a test-tube containing 1.8 ml of 3 % trichloroacetic acid (TCA). The test-tube was shaken gently to ensure proper mixing and allowed to stand for 5-10 min. The test-tube was further centrifuged for 10 min at 3000 rpm after which 1 ml of the clear supernatant layer was collected and analyzed spectrophotometrically without dilution at 280 nm. The blank was a 3 % solution of TCA. An absorption spectrum previously constructed for a solution of cefuroxime sodium in TCA did not show any shift from the earlier wavelength of maximum absorption; an indication that no significant interaction occurred between the two compounds (i.e. TCA and cefuroxime sodium).
Statistical data analysis
Statistical data analysis were performed using the student's t-test with p ≤ 0.05 as the minimal level of significance.
RESULTS
The results of the water sorption studies carried out in two different media(SIF and SGF) are shown in Figs. 1 and 2 . It can be seen from these figures that microspheres prepared from admixtures of gelatin and S-mucin showed higher swelling tendency especially in SGF where between 35 and 82 % water sorption was recorded when compared to that prepared from gelatin only which showed a water sorption of 25 %. Water sorption for all the batches of microspheres including that formulated with gelatin only was quite high in SIF and ranged between 150 and 290 %. The highest water sorption capacity was shown by microspheres formulated with equal portions of gelatin and mucin and this was followed closely by The release profile of cefuroxime sodium from the microspheres in SIF is shown in Fig. 3 . There was an initial rapid release of cefuroxime sodium from the microspheres in SIF within 30 min and this was followed by a much slower release over the next 150 min. Drug release was highest from microspheres prepared with equal proportions of S-mucin and gelatin (1:1) where up to 85 % of the drug was released within 3 h. A characteristic feature of the release profile of cefuroxime sodium from the microspheres in SIF is the biphasic pattern of release.
The plasma concentration versus time curves for cefuroxime sodium, after rectal administration to male Wistar rats, are depicted in Fig. 4 . The areas under the plasma level versus time curves (AUC) were evaluated using the trapezoid rule based on a non-compartmental pharmacokinetic analysis. The pharmacokinetic parameters as can be seen from Fig. 4 showed a higher peak plasma concentration of 4.5±0.39 µg/ml for microspheres based on gelatin-mucin in the ratio 1:1 when compared to that for the control (3.5±0.45 µg/ml) or the microspheres based on gelatin only (4.0±0.45 µg/ml). The mean AUC was shown to be dependent on the formulation with values of 168±1.93 µg.h/ml for the control , 262±3.47 µg.h/ml for microspheres based on gelatin only and 328±2.55 µg.h/ml for microspheres formulated with gelatin and mucin in the ratio 1:1 which gives an indication that the inclusion of mucin in the microsphere formulation enhanced the rectal bioavailability of cefuroxime sodium.
DISCUSSION
The water sorption behaviour in the two media may be an indication of a probable modification of the gelatin microspheres by the mucin. The higher amount and rate of water absorption in SIF than in SGF may also be attributable to the type of gelatin (type A) used in preparing the microspheres. This type of gelatin is known to be produced from acidic precursors and would, therefore, be expected to swell more in an alkaline environment of the SIF than in SGF.
The wide variation in the drug contents of the different batches of the microspheres could be a consequence of the varying degrees of drug sedimentation and the relative partitioning of cefuroxime sodium between the dispersed and continuous phases of the emulsion prior to cross-linking of the polymer admixtures.
The rapid release in the first 30 min as is evident in Fig. 3 is possibly due to a burst effect caused by the leaching out of the unentrapped drug adhering to the surface of the microspheres after the initial rapid hydration and swelling. The high and rapid release of cefuroxime sodium from the microspheres in SIF, in addition to the burst effect, may also may be a result of the high rate of hydration and swelling of the microspheres in SIF , which, in turn, could be, attributable to the type of gelatin (type A) used in preparing the microspheres. The subsequent slow release phase could be a consequence of the decreasing residual amount of drug in the microspheres and the build-up of drug concentration in the dissolution medium in the course of time. This indicates that once the drug adhering to the microspheric surface has leached, the drug release obeys the Higuchi membrane diffusion controlled model 19 . Further analysis of the release of cefuroxime sodium from the microspheres was done using the Fickian diffusion model 20 to determine the mechanism of release. To understand the release mechanism of cefuroxime sodium from the microspheres, the release rate was described with the following equations 20 :
M t /M is the fraction of drug released at time t, K is a kinetic constant that incorporates the structural and geometric characteristics of the release device and n is the release exponent indicative of the mechanism of release. An n value of 1.0 corresponds to zero-order release kinetics (case-II transport). An n value greater than 0.5 but less than 1.0 means an anomalous (non-Fickian) diffusion release model; n = 0.5 indicates Fickian diffusion while n > 1.0 indicates a super case-II relaxational release 21 . The kinetic parameters, n and K as calculated from plots of log M t /M versus log t for cefuroxime sodium are presented in Table 1 where can be seen that the values of the release exponent, n, were in the range 0.48 to 0.96, indicating that the release of cefuroxime sodium from the microspheres in SIF occurred predominantly by diffusion following an initial non-Fickian transport.
Compared with the control and microspheres formulated with gelatin only, it is interesting to note that the bioavailability of cefuroxime sodium via the rectal route was higher (AUC = 328 µg.h ml -1 ) from microspheres formulated with an admixture of S-mucin and gelatin in the ratio 1:1. The in vitro release study in SIF showed that higher amount of cefuroxime sodium was released from the 1:1 mucin-gelatin based microspheres than from gelatin-only based microspheres. There is, therefore, a correlation between the in vitro release and in vivo availability. Interestingly, the peak plasma concentration followed a pattern closely similar to the AUC and this provided a further index of the bioavailability of the drug studied. The generally high AUC values obtained for the microspheres may be an indication that the absorption of cefuroxime sodium was both rapid and complete and that the drug may have bypassed the hepatic first-pass metabolism. It is noteworthy to point out that adequate precautions were taken to deposit the encapsulated microspheres on the lower or middle part of the rat's rectum with the expectation of causing the absorbed drug to drain directly into the general circulation via either the lower or middle haemorrhoidal veins. This expectation may have been realized considering the high AUC values obtained for the microspheres. It is also deducible from Fig. 4 that the bioavailability as well as the time to attain peak peak plasma level for cefuroxime sodium was generally higher from the microspheres in comparison with that of the control.
CONCLUSION
The results have shown that the entrapment of cefuroxime sodium in gelatin-mucin microspheres can be used to improve the rectal delivery of the drug. Thus, the findings may be exploited in the design of a rectal delivery system for the drug.
